Structure-activity relationships of benzothiazole-based Hsp90 C-terminal-domain inhibitors
Abstract
Heat shock protein 90 (Hsp90) is a chaperone responsible for the maturation of many cancer-related proteins, and is therefore an important target for the design of new anticancer agents. Several Hsp90 N-terminal domain inhibitors have been evaluated in clinical trials, but none have been approved as cancer therapies. This is partly due to induction of the heat shock response, which can be avoided using Hsp90 C-terminal-domain (CTD) inhibition. Several structural features have been shown to be useful in the design of Hsp90 CTD inhibitors, including an aromatic ring, a cationic center and the benzothiazole moiety. This study established a previously unknown link between these structural motifs. Using ligand-based design methodologies and structure-based pharmacophore models, a library of 29 benzothiazole-based Hsp90 CTD inhibitors was prepared, and their antiproliferative activities were evaluated in MCF-7 breast cancer cells. Several showed low-micromolar IC50, with the most potent being compounds 5g and 9i (IC50, 2.8 - 0.1, 3.9 - 0.1 [micro]M, respectively). Based on these results, a ligand-based structure-activity relationship model was built, and molecular dynamics simulation was performed to elaborate the binding mode of compound 9i. Moreover, compound 9i showed degradation of Hsp90 client proteins and no induction of the heat shock response.
Keywords
zaviralci;benzotiazol;alosterija;allosteric;Hsp90;benzothiazole;cancer;inhibitor;cancer therapy;
Data
| Language: | English |
|---|---|
| Year of publishing: | 2021 |
| Typology: | 1.01 - Original Scientific Article |
| Organization: | UL FFA - Faculty of Pharmacy |
| UDC: | 616-006-085 |
| COBISS: |
73315587
|
| ISSN: | 1999-4923 |
| Views: | 127 |
| Downloads: | 58 |
| Average score: | 0 (0 votes) |
| Metadata: |
|
Other data
| Secondary language: | Slovenian |
|---|---|
| Secondary keywords: | Rak (medicina);Zdravljenje; |
| Type (COBISS): | Article |
| Pages: | str. 1-31 |
| Volume: | ǂVol. ǂ13 |
| Issue: | ǂiss. ǂ8 |
| Chronology: | 2021 |
| DOI: | 10.3390/pharmaceutics13081283 |
| ID: | 15003872 |
Recommended works:
Structure-activity relationships of benzothiazole-based Hsp90 C-terminal-domain inhibitors
2021,
no subtitle data available
In silico discovery and optimisation of a novel structural class of Hsp90 C-terminal domain inhibitors
2022,
no subtitle data available
Sinteza piperidinskih zaviralcev C-končne domene proteina Hsp90 s protitumornim delovanjem
2020,
no subtitle data available
Vpliv strukture terciarnih aminov na antiproliferativno delovanje piperidinskih zaviralcev C-končne domene proteina Hsp90
2021,
no subtitle data available
Discovery of novel Hsp90 C-terminal inhibitors using 3D-pharmacophores derived from molecular dynamics simulations
2020,
no subtitle data available